Literature DB >> 11122803

Do we need a new strategy to treat metastatic breast cancer?

J R Bertino1, O A O'Connor.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 11122803     DOI: 10.1007/s11912-999-0015-5

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  6 in total

1.  Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA.

Authors:  S C Zhao; D Banerjee; S Mineishi; J R Bertino
Journal:  Hum Gene Ther       Date:  1997-05-20       Impact factor: 5.695

Review 2.  Kinetic concepts in the systemic drug therapy of breast cancer.

Authors:  L Norton
Journal:  Semin Oncol       Date:  1999-02       Impact factor: 4.929

3.  Systemic therapy in node-negative patients: updated findings from NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project.

Authors:  B Fisher; C Redmond
Journal:  J Natl Cancer Inst Monogr       Date:  1992

4.  Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.

Authors:  Z Rahman; J Kavanagh; R Champlin; R Giles; E Hanania; S Fu; Z Zu; R Mehra; F Holmes; A Kudelka; D Claxton; C Verschraegen; J Gajewski; M Andreeff; S Heimfeld; R Berenson; D Ellerson; L Calvert; E Mechetner; T Holzmayer; A Dayne; J Hamer; C Bachier; J Ostrove; A Deisseroth
Journal:  Clin Cancer Res       Date:  1998-11       Impact factor: 12.531

5.  Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.

Authors:  R Fanin; D Banerjee; M Volkenandt; M Waltham; W W Li; A P Dicker; B I Schweitzer; J R Bertino
Journal:  Mol Pharmacol       Date:  1993-07       Impact factor: 4.436

Review 6.  The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity.

Authors:  E Frei; A Elias; C Wheeler; P Richardson; W Hryniuk
Journal:  Clin Cancer Res       Date:  1998-09       Impact factor: 12.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.